Osman Melih Topcuoglu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Osman Melih Topcuoglu has a total of 71 co-authors. Here are the top co-authors by number of shared publications:
- Ayşegul Gormez
Department of Radiology, Yeditepe University Hospitals, Kosuyolu, Istanbul, 34718, Turkey
6 shared publications - Betul Uzunoglu
Radiology Resident, Yeditepe University Hospitals , Istanbul
4 shared publications - Cüneyt Türkmen
Department of Nuclear Medicine, Yeditepe University Hospitals, Kosuyolu, Istanbul, 34752, Turkey
3 shared publications - Türkay Toklu
Department of Nuclear Medicine, Yeditepe University Hospitals, Kosuyolu, Istanbul, Turkey
3 shared publications - Çetin Murat Altay
University of Health Sciences, Turkey
3 shared publications - Elif Dilara Topcuoglu
Department of Radiology, University of Health Sciences Umraniye Training and Research Hospital, Umraniye, Turkey
2 shared publications
Latest Publications
- Open Access
- 22 May 2026
- Published by Springer Nature in European Journal of Nuclear Medicine and Molecular Imaging
Tumor absorbed dose and outcomes after Y-90 glass radioembolization for colorectal liver metastases: does dose escalation improve survival in real-world practice?
Purpose: To assess the dose-response and dose-survival outcomes of yttrium-90 (Y90) transarterial radioembolization (TARE) using Therasphere microspheres in patients with colorectal cancer liver metastases (CRCLM). Material and methods: Between May 2014 and December 2024, patients with chemorefractory CRCLM who underwent Y90 TARE using glass microspheres were retrospectively included. Patients were divided into two groups according to tumour absorbed dose (TAD): TAD<189 Gy (group 1) and TAD ≥189 Gy (group 2). The primary outcomes were overall survival (OS) and hepatic progression-free survival (hPFS). The secondary outcome was the objective response rate (ORR). Results: A total of seventy-eight patients with a mean age of 69.9±11.2 years (range 41 to 91 years) were included. The median tumor dose and the median OS were 171.5 Gy (IQR; 147-200 Gy) and 8.9 months ( IQR; 5-14 months), respectively. The median TAD for groups 1 (n=46) and 2 (n=32) was 150 Gy (IQR; 122-166 Gy) and 202 Gy (IQR; 195-232 Gy), respectively. The median OS and hPFS for group 1 versus group 2 were 9.4 months (IQR; 6.7–17.7 months) and 5.2 months (IQR; 4-6.7 months) versus 7.1 months (IQR; 5–10.7 months) and 5.5 months (IQR; 4.2-6.7 months), respectively and were not significantly different (p = .107 and p = .663, respectively). The ORR did not differ significantly between the two groups (p = .943). Conclusion: In a real-world population of heavily pretreated patients with CRCLM, escalation of TAD beyond 189 Gy did not translate into improved survival, highlighting the dominant impact of advanced disease burden and extrahepatic progression.
- 22 May 2026
- Published by Springer Nature in European Journal of Nuclear Medicine and Molecular Imaging
Open AccessTumor absorbed dose and outcomes after Y-90 glass radioembolization for colorectal liver metastases: does dose escalation improve survival in real-world practice?
Purpose: To assess the dose-response and dose-survival outcomes of yttrium-90 (Y90) transarterial radioembolization (TARE) using Therasphere microspheres in patients with colorectal cancer liver metastases (CRCLM). Material and methods: Between May 2014 and December 2024, patients with chemorefractory CRCLM who underwent Y90 TARE using glass microspheres were retrospectively included. Patients were divided into two groups according to tumour absorbed dose (TAD): TAD<189 Gy (group 1) and TAD ≥189 Gy (group 2). The primary outcomes were overall survival (OS) and hepatic progression-free survival (hPFS). The secondary outcome was the objective response rate (ORR). Results: A total of seventy-eight patients with a mean age of 69.9±11.2 years (range 41 to 91 years) were included. The median tumor dose and the median OS were 171.5 Gy (IQR; 147-200 Gy) and 8.9 months ( IQR; 5-14 months), respectively. The median TAD for groups 1 (n=46) and 2 (n=32) was 150 Gy (IQR; 122-166 Gy) and 202 Gy (IQR; 195-232 Gy), respectively. The median OS and hPFS for group 1 versus group 2 were 9.4 months (IQR; 6.7–17.7 months) and 5.2 months (IQR; 4-6.7 months) versus 7.1 months (IQR; 5–10.7 months) and 5.5 months (IQR; 4.2-6.7 months), respectively and were not significantly different (p = .107 and p = .663, respectively). The ORR did not differ significantly between the two groups (p = .943). Conclusion: In a real-world population of heavily pretreated patients with CRCLM, escalation of TAD beyond 189 Gy did not translate into improved survival, highlighting the dominant impact of advanced disease burden and extrahepatic progression.
- Open Access
- 28 January 2026
- Published by Springer Nature in Japanese Journal of Radiology
- Vol. 44 (6) , 1062-1070
18F-FDG PET radiomics model for predicting TARE response in patients with colorectal cancer liver metastases
Purpose: Predicting treatment response in patients with colorectal cancer liver metastases (CRCLM) who have undergone transarterial radioembolization (TARE) based on pre-procedural fluorine-18-fluoro-deoxy glucose positron emission tomography ( 18 F-FDG PET) radiomics and clinical information. Materials and methods: Patients with CRCLM who underwent TARE, between March 2015 and May 2025, were consecutively included. Largest tumors were segmented semiautomatically using pre-procedural 18 F-FDG PET images. Radiomics features were extracted, clinical information were collected. Two datasets were created comprising radiomics-only and clinico-radiomic features. Datasets were divided 60:40 for training and testing. Top 5 features were selected based on feature importances. Random Forest, Extreme Gradient Boosting, Logistic Regression models were trained. Test-set area under the curves (AUCs) for predicting post-treatment target lesion local progression were calculated and compared using DeLong’s test. Sensitivity, specificity, accuracy and F1 scores were calculated at the optimal cut-offs. Results: Seventy-four patients out of 96 patients were included. Top five selected features in the radiomics-only dataset were Coarseness, IMC1, Zone Entropy, Size-Zone Non-Uniformity, and Strength. In the clinico-radiomic dataset, AST and ALT levels were substituted among the top five features. Radiomics-only features demonstrated AUCs ranging from 0.90 (95% CI 0.71–1) to 0.81 (95% CI 0.51–1) in the test-set while clinico-radiomics dataset AUCs varied between 0.88 (95% CI 0.51–1) and 0.84 (0.62–1). Conclusion: 18 F-FDG PET radiomics based models can predict the local response to TARE in patients with CRCLM, in this series.
- 28 January 2026
- Published by Springer Nature in Japanese Journal of Radiology
- Vol. 44 (6) , 1062-1070
Open Access18F-FDG PET radiomics model for predicting TARE response in patients with colorectal cancer liver metastases
Purpose: Predicting treatment response in patients with colorectal cancer liver metastases (CRCLM) who have undergone transarterial radioembolization (TARE) based on pre-procedural fluorine-18-fluoro-deoxy glucose positron emission tomography ( 18 F-FDG PET) radiomics and clinical information. Materials and methods: Patients with CRCLM who underwent TARE, between March 2015 and May 2025, were consecutively included. Largest tumors were segmented semiautomatically using pre-procedural 18 F-FDG PET images. Radiomics features were extracted, clinical information were collected. Two datasets were created comprising radiomics-only and clinico-radiomic features. Datasets were divided 60:40 for training and testing. Top 5 features were selected based on feature importances. Random Forest, Extreme Gradient Boosting, Logistic Regression models were trained. Test-set area under the curves (AUCs) for predicting post-treatment target lesion local progression were calculated and compared using DeLong’s test. Sensitivity, specificity, accuracy and F1 scores were calculated at the optimal cut-offs. Results: Seventy-four patients out of 96 patients were included. Top five selected features in the radiomics-only dataset were Coarseness, IMC1, Zone Entropy, Size-Zone Non-Uniformity, and Strength. In the clinico-radiomic dataset, AST and ALT levels were substituted among the top five features. Radiomics-only features demonstrated AUCs ranging from 0.90 (95% CI 0.71–1) to 0.81 (95% CI 0.51–1) in the test-set while clinico-radiomics dataset AUCs varied between 0.88 (95% CI 0.51–1) and 0.84 (0.62–1). Conclusion: 18 F-FDG PET radiomics based models can predict the local response to TARE in patients with CRCLM, in this series.
- 22 October 2025
- Published by Elsevier in Journal of Vascular and Interventional Radiology
- Vol. 36 (11) , 1821-1822
Lessons in IR: Endovascular Repair of Brachiocephalic Vein Perforation and Hemothorax during Tunneled Dialysis Catheter Placement
- 22 October 2025
- Published by Elsevier in Journal of Vascular and Interventional Radiology
- Vol. 36 (11) , 1821-1822
Lessons in IR: Endovascular Repair of Brachiocephalic Vein Perforation and Hemothorax during Tunneled Dialysis Catheter Placement
- 11 September 2025
- Published by Elsevier in Journal of Vascular and Interventional Radiology
- Vol. 37 (1) , 107833
Tumor-Absorbed Dose, Metabolic Response, and Survival after Yttrium-90 Radioembolization in Patients with Breast Cancer Liver Metastases
- 11 September 2025
- Published by Elsevier in Journal of Vascular and Interventional Radiology
- Vol. 37 (1) , 107833
Tumor-Absorbed Dose, Metabolic Response, and Survival after Yttrium-90 Radioembolization in Patients with Breast Cancer Liver Metastases
- Open Access
- 24 March 2025
- Published by Wiley in Otolaryngology–Head and Neck Surgery
- Vol. 173 (1) , 115-125
Can Manual Therapy Alter Muscle Stiffness in Patients With Spinal Accessory Nerve Injury?
Objective: Shoulder and neck dysfunctions resulting from spinal accessory nerve injury impair quality of life. This study aims to investigate the effects of manual therapy in combination with standard physiotherapy on the mechanical properties of muscle, neck and shoulder function, pain, and quality of life in head and neck cancer patients.Study Design: Prospective, randomized, controlled, double‐blind clinical trial.Setting: Department of Otorhinolaryngology Head and Neck Surgery of a university hospital.Methods: A total of 26 participants were randomized into two groups. The control group (n = 11) received standard physiotherapy including therapeutic exercises, scar tissue massage, and education. The intervention group (n = 10) received manual therapy consisting of soft tissue, myofascial release, and mobilization techniques in combination with standard physiotherapy. Outcome measures were mechanical properties of muscle, neck and shoulder active range of motion, shoulder pain and disability, and quality of life.Results: Upper trapezius and sternocleidomastoid muscle stiffness increased significantly in the control group (P < .01), whereas a significant reduction was observed in the intervention group compared to the control group (P = .001). A reduction in muscle thickness was observed bilaterally in both groups (P < .01). Moreover, all participants showed improvements in neck and shoulder active range of motion, shoulder pain, and quality of life (P < .01).Conclusion: Manual therapy in addition to standard physiotherapy was more effective in improving neck and shoulder function, quality of life, and reducing muscle stiffness compared to standard physiotherapy alone. Therefore, clinicians should consider incorporating manual therapy into their treatment protocols to optimize patient outcomes.
- 24 March 2025
- Published by Wiley in Otolaryngology–Head and Neck Surgery
- Vol. 173 (1) , 115-125
Open AccessCan Manual Therapy Alter Muscle Stiffness in Patients With Spinal Accessory Nerve Injury?
Objective: Shoulder and neck dysfunctions resulting from spinal accessory nerve injury impair quality of life. This study aims to investigate the effects of manual therapy in combination with standard physiotherapy on the mechanical properties of muscle, neck and shoulder function, pain, and quality of life in head and neck cancer patients.Study Design: Prospective, randomized, controlled, double‐blind clinical trial.Setting: Department of Otorhinolaryngology Head and Neck Surgery of a university hospital.Methods: A total of 26 participants were randomized into two groups. The control group (n = 11) received standard physiotherapy including therapeutic exercises, scar tissue massage, and education. The intervention group (n = 10) received manual therapy consisting of soft tissue, myofascial release, and mobilization techniques in combination with standard physiotherapy. Outcome measures were mechanical properties of muscle, neck and shoulder active range of motion, shoulder pain and disability, and quality of life.Results: Upper trapezius and sternocleidomastoid muscle stiffness increased significantly in the control group (P < .01), whereas a significant reduction was observed in the intervention group compared to the control group (P = .001). A reduction in muscle thickness was observed bilaterally in both groups (P < .01). Moreover, all participants showed improvements in neck and shoulder active range of motion, shoulder pain, and quality of life (P < .01).Conclusion: Manual therapy in addition to standard physiotherapy was more effective in improving neck and shoulder function, quality of life, and reducing muscle stiffness compared to standard physiotherapy alone. Therefore, clinicians should consider incorporating manual therapy into their treatment protocols to optimize patient outcomes.
- 22 November 2024
- Published by Elsevier in Clinical Imaging
- Vol. 117, 110366
A real-world comparison of the diagnostic performances of six different TI-RADS guidelines, including ACR-/Kwak-/K-/EU-/ATA-/C-TIRADS
- 22 November 2024
- Published by Elsevier in Clinical Imaging
- Vol. 117, 110366
A real-world comparison of the diagnostic performances of six different TI-RADS guidelines, including ACR-/Kwak-/K-/EU-/ATA-/C-TIRADS
- Open Access
- 10 May 2024
- Published by Oxford University Press (OUP) in British Journal of Radiology
- Vol. 97 (1159) , 1255-1260
Are survival outcomes dependent on the tumour dose threshold of 139 Gy in patients with chemorefractory metastatic colorectal cancer treated with yttrium-90 radioembolization using glass particles? A real-world single-centre study
To compare the survival and objective response rate (ORR) of the patients receiving estimated tumour absorbed dose (ETAD) P = .181 and P = .366, respectively). ORR did not show significant difference between the groups (P = .432). In real-world practice, no significant difference was found in OS, hPFS, and ORR between patients who received ETAD <140 Gy versus ETAD ≥140 Gy in patients with CRCLM, in this series. This study demonstrated that increased tumour absorbed doses in radioembolization may not provide additional significant advantage for OS and hPFS for patients with CRCLM.
- 10 May 2024
- Published by Oxford University Press (OUP) in British Journal of Radiology
- Vol. 97 (1159) , 1255-1260
Open AccessAre survival outcomes dependent on the tumour dose threshold of 139 Gy in patients with chemorefractory metastatic colorectal cancer treated with yttrium-90 radioembolization using glass particles? A real-world single-centre study
To compare the survival and objective response rate (ORR) of the patients receiving estimated tumour absorbed dose (ETAD) P = .181 and P = .366, respectively). ORR did not show significant difference between the groups (P = .432). In real-world practice, no significant difference was found in OS, hPFS, and ORR between patients who received ETAD <140 Gy versus ETAD ≥140 Gy in patients with CRCLM, in this series. This study demonstrated that increased tumour absorbed doses in radioembolization may not provide additional significant advantage for OS and hPFS for patients with CRCLM.
- Open Access
- 18 August 2023
- Published by Galenos Yayinevi in Diagnostic and Interventional Radiology
- Vol. 30 (5) , 318-324
Percutaneous nephrostomy in infants: a 20-year single-center experience
PURPOSE To investigate the safety and efficacy of the imaging-guided percutaneous nephrostomy (PCN) procedure in infants. METHODS A total of 75 (50 boys; 66.7%) patients with a mean age of 121 days (range, 1-351 days) who underwent PCN over a period of 20 years were included in this retrospective study. For each patient, PCN indications, catheter size, the mean duration of catheterization, complications, and the procedure performed following nephrostomy were recorded. Technical success was determined based on the successful placement of the nephrostomy catheter within the pelvicalyceal system. Clinical success was defined as the complete resolution of hydronephrosis and improvement in renal function tests during follow-up. In patients with urinary leakage, technical and clinical success was determined based on the resolution of leakage. RESULTS The technical success rate was 100%, and no procedure-related mortality was observed. In 11 patients (14.7%), bilateral PCN was performed. The most frequent indication of PCN was ureteropelvic junction obstruction (n = 41, 54.7%). Procedure-related major complications were encountered in two patients (methemoglobinemia and respiratory arrest caused by the local anesthetic agent in one patient and the development of urinoma caused by urinary leakage from the puncture site in the other). Mild urinary leakage was the only minor complication that occurred and only in one patient. Catheter-related complications were managed through replacement or revision surgery in 16 patients (21.3%). CONCLUSION Imaging-guided PCN is a feasible and effective procedure with high technical success and low major complication rates, and it is useful for protecting kidney function in infants.
- 18 August 2023
- Published by Galenos Yayinevi in Diagnostic and Interventional Radiology
- Vol. 30 (5) , 318-324
Open AccessPercutaneous nephrostomy in infants: a 20-year single-center experience
PURPOSE To investigate the safety and efficacy of the imaging-guided percutaneous nephrostomy (PCN) procedure in infants. METHODS A total of 75 (50 boys; 66.7%) patients with a mean age of 121 days (range, 1-351 days) who underwent PCN over a period of 20 years were included in this retrospective study. For each patient, PCN indications, catheter size, the mean duration of catheterization, complications, and the procedure performed following nephrostomy were recorded. Technical success was determined based on the successful placement of the nephrostomy catheter within the pelvicalyceal system. Clinical success was defined as the complete resolution of hydronephrosis and improvement in renal function tests during follow-up. In patients with urinary leakage, technical and clinical success was determined based on the resolution of leakage. RESULTS The technical success rate was 100%, and no procedure-related mortality was observed. In 11 patients (14.7%), bilateral PCN was performed. The most frequent indication of PCN was ureteropelvic junction obstruction (n = 41, 54.7%). Procedure-related major complications were encountered in two patients (methemoglobinemia and respiratory arrest caused by the local anesthetic agent in one patient and the development of urinoma caused by urinary leakage from the puncture site in the other). Mild urinary leakage was the only minor complication that occurred and only in one patient. Catheter-related complications were managed through replacement or revision surgery in 16 patients (21.3%). CONCLUSION Imaging-guided PCN is a feasible and effective procedure with high technical success and low major complication rates, and it is useful for protecting kidney function in infants.
- Open Access
- 30 April 2023
- Published by Selcuk University in Genel Tıp Dergisi
- Vol. 33 (2) , 123-127
Does Gadopentetate Dimeglumine Induce Gadolinium Accumulation in the Brains of Children?
Aim: To determine T1-weighted (T1W) signal intensity (SI) differences in the dentate nucleus (DN) and globus pallidus (GP) following contrast enhanced magnetic resonance imaging (MRI) with multiple gadopentetate dimeglumine administrations in a group of pediatric patients. Methods and materials: This retrospective study included children with at least two enhanced brain MRIs. All patients received gadopentetate dimeglumine intravenously (0.1 mmol/kg). SI measurements were done by drawing five region of interests (ROI) on dentate nuclei (DN) and globus pallidi (GP) bilaterally and cerebro-spinal fluid (CSF) in unenhanced T1W images. Student t-test was used for comparison of SI. Pearson correlation was calculated for the correlation between the SI and the number of gadolinium administrations. Results: A total of 31 children (age range: 3-17 years; mean 10.6±4.3 years) were included. There was no significant difference between the first and the third MRI scans by means of the T1 SI ratios: right and left DN/CSF, right and left GP/CSF (P =0.543, P =0.599, P =0.803, P =0.730, respectively). 18 patients received more than two gadopentetate dimeglumine, the mean number of administrations was 5±3. A significant difference was detected between first and last MRI scans; right and left DN/CSF, right and left GP/CSF (P=0.0004, P=0.0008, P=0.0001, P=0.014 respectively). Correlation between the number of gadopentetate dimeglumine administrations and the SI for right and left DN/CSF, right and left GP/CSF (r=0.13, r=0.13, r=0.09 and r=0.12, respectively) was poor. Conclusion: There was no significant T1 SI increase for children with at least two gadopentetate dimeglumine administrations but after multiple administrations, significant T1 SI increase was found in this series.
- 30 April 2023
- Published by Selcuk University in Genel Tıp Dergisi
- Vol. 33 (2) , 123-127
Open AccessDoes Gadopentetate Dimeglumine Induce Gadolinium Accumulation in the Brains of Children?
Aim: To determine T1-weighted (T1W) signal intensity (SI) differences in the dentate nucleus (DN) and globus pallidus (GP) following contrast enhanced magnetic resonance imaging (MRI) with multiple gadopentetate dimeglumine administrations in a group of pediatric patients. Methods and materials: This retrospective study included children with at least two enhanced brain MRIs. All patients received gadopentetate dimeglumine intravenously (0.1 mmol/kg). SI measurements were done by drawing five region of interests (ROI) on dentate nuclei (DN) and globus pallidi (GP) bilaterally and cerebro-spinal fluid (CSF) in unenhanced T1W images. Student t-test was used for comparison of SI. Pearson correlation was calculated for the correlation between the SI and the number of gadolinium administrations. Results: A total of 31 children (age range: 3-17 years; mean 10.6±4.3 years) were included. There was no significant difference between the first and the third MRI scans by means of the T1 SI ratios: right and left DN/CSF, right and left GP/CSF (P =0.543, P =0.599, P =0.803, P =0.730, respectively). 18 patients received more than two gadopentetate dimeglumine, the mean number of administrations was 5±3. A significant difference was detected between first and last MRI scans; right and left DN/CSF, right and left GP/CSF (P=0.0004, P=0.0008, P=0.0001, P=0.014 respectively). Correlation between the number of gadopentetate dimeglumine administrations and the SI for right and left DN/CSF, right and left GP/CSF (r=0.13, r=0.13, r=0.09 and r=0.12, respectively) was poor. Conclusion: There was no significant T1 SI increase for children with at least two gadopentetate dimeglumine administrations but after multiple administrations, significant T1 SI increase was found in this series.
- 3 April 2023
- Published by Springer Nature in CardioVascular and Interventional Radiology
- Vol. 46 (5) , 574-578
Prediction of Bleeding by the PRECISE-DAPT Score in Patients with Carotid Artery Stenting
Purpose The predicting bleeding complications in patients undergoing stent implantation and the subsequent dual antiplatelet therapy (PRECISE-DAPT) score predicts the risk of bleeding in patients with dual antiplatelet therapy (DAPT) after percutaneous coronary interventions (PCIs). Patients with carotid artery stenting (CAS) are also treated with DAPT. In this study, we aimed to investigate the performance of the PRECISE-DAPT score in predicting bleeding in patients with CAS. Methods Patients who had CAS between January 2018 and December 2020 were retrospectively enrolled. The PRECISE-DAPT score was calculated for each patient. The patients were divided into two groups based on their PRECISE-DAPT score: low < 25 and high ≥ 25. Bleeding and ischemia complications and laboratory data among the two groups were compared. Results A total of 120 patients with a mean age of 67.3 ± 9.7 years were included. Forty-three patients had high PRECISE-DAPT scores, and 77 patients had low PRECISE-DAPT scores. Six patients developed bleeding events during the six-month follow-up, and five of them were in the PRECISE DAPT score ≥ 25 group. The difference between the two groups regarding bleeding events at six months was significant (P = 0.022). Conclusion The PRECISE-DAPT score might be used for predicting the bleeding risk in patients with CAS, and the bleeding rate was significantly higher in patients with a PRECISE-DAPT score ≥ 25.
- 3 April 2023
- Published by Springer Nature in CardioVascular and Interventional Radiology
- Vol. 46 (5) , 574-578
Prediction of Bleeding by the PRECISE-DAPT Score in Patients with Carotid Artery Stenting
Purpose The predicting bleeding complications in patients undergoing stent implantation and the subsequent dual antiplatelet therapy (PRECISE-DAPT) score predicts the risk of bleeding in patients with dual antiplatelet therapy (DAPT) after percutaneous coronary interventions (PCIs). Patients with carotid artery stenting (CAS) are also treated with DAPT. In this study, we aimed to investigate the performance of the PRECISE-DAPT score in predicting bleeding in patients with CAS. Methods Patients who had CAS between January 2018 and December 2020 were retrospectively enrolled. The PRECISE-DAPT score was calculated for each patient. The patients were divided into two groups based on their PRECISE-DAPT score: low < 25 and high ≥ 25. Bleeding and ischemia complications and laboratory data among the two groups were compared. Results A total of 120 patients with a mean age of 67.3 ± 9.7 years were included. Forty-three patients had high PRECISE-DAPT scores, and 77 patients had low PRECISE-DAPT scores. Six patients developed bleeding events during the six-month follow-up, and five of them were in the PRECISE DAPT score ≥ 25 group. The difference between the two groups regarding bleeding events at six months was significant (P = 0.022). Conclusion The PRECISE-DAPT score might be used for predicting the bleeding risk in patients with CAS, and the bleeding rate was significantly higher in patients with a PRECISE-DAPT score ≥ 25.